A double point mutation in the DNA-binding region of Egr2 switches its function from inhibition to induction of proliferation: A potential contribution to the development of congenital hypomyelinating neuropathy.

Source:http://linkedlifedata.com/resource/pubmed/id/16872830

Download in:

View as

General Info

PMID
16872830